" /> Zolbetuximab - CISMeF





Preferred Label : Zolbetuximab;

NCIt synonyms : Claudiximab; GC 182; Zolbetuximab-clzb;

NCIt definition : A chimeric immunoglobulin G1 (IgG1) monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform of claudin-18), with potential immunostimulating and antineoplastic activities. Upon administration, zolbetuximab specifically targets and binds to CLDN18.2 expressed on tumor cells. This may kill CLDN18.2-expressing tumor cells by antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), and inhibit cell proliferation. CLDN18.2, a tight junction protein and stomach-specific isoform of claudin-18, is expressed on a variety of tumor cells. Its expression in healthy tissues is strictly confined to short-lived differentiated epithelial cells of the gastric mucosa.;

UNII : TF5MPQ8WGY;

CAS number : 1496553-00-4;

Drug name : Vyloy;

Molecule name : IMAB-362; IMAB 362;

NCI Metathesaurus CUI : CL554291;

Codes from synonyms : 127128;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.